Kinase Approved News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kinase Approved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kinase Approved Today - Breaking & Trending Today

Takeda Announces China NMPA Approval of LIVTENCITY maribavir for the Treatment of Adults With Posttransplant Cytomegalovirus CMV Refractory to Prior Therapies

Published: December 22, 2023

Takeda Announces China NMPA Approval of LIVTENCITY maribavir for the Treatment of Adults With Posttransplant Cytomegalovirus CMV Refractory to Prior Therapies

Source: businesswireindia.com

Related Topics:

United StatesRamona SequeiraClin VirolEuropean CommissionExchange CommissionInternational MediaTakeda Pharmaceutical Company LimitedNational Medical Products AdministrationGlobal Portfolio DivisionEuropean UnionTherapeutic Goods AdministrationHealth CanadaChina CenterOnly InhibitorKinase ApprovedAdults With Post TransplantDemonstrating Maribavir Was SuperiorConventional TherapiesMost CommonSerious Post Transplant InfectionsCan LeadTransplanted OrganBreakthrough Therapy DesignationDrug EvaluationStudy Week